Ultime notizie per Quantum-Si (NASDAQ:QSI) Azioni

Quantum-Si

Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si Inc

WisdomTree U.S. Short Term Corporate Bond Fund

Pacer Metaurus Nasdaq 100 Dividend Multiplier 600 ETF

Village Farms International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) reported its financial results Thursday for the third quarter ended Sep. 30, 2024. The British Columbia-based cannabis company disclosed revenue of $83.37 million, compared to $69.51 million in the same period a year ago.
"Strong performance in our fresh produce business, continued growth in Canadian cannabis and a doubling of international medicinal cannabis sales drove 20% year-over-year growth in consolidated sales, with both positive Adjusted EBITDA and cash flow from operations during the third quarter," stated Michael DeGiglio, president and CEO. "Our Canadian cannabis business continues to deliver strong growth with leading market share as we realized revenue growth in all sales channels and positive EBITDA and operating cash flow. We were once again the fastest growing producer in Canada over the last year in terms of market share and, for the first time ever, were number one in Quebec, making us the top producer in Canada's two most populus provinces."
 Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/41792417/cannabis-reit-giant-iipr-reports-q3-39-7m-profit-despite-rent-delays-in-sector">Cannabis REIT Giant IIPR Reports Q3 $39.7M Profit Despite Rent Delays In Sector</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h2 class="wp-block-heading">Q3 Financial Highlights</h2>
<ul>
<li>Gross profit was $15.71 million, compared to $14.62 million in the same quarter last year.</li>
</ul>
<ul>
<li>Net loss was $800,000 or $0.01 per share, compared to loss of $1.3 million or $0.01 per share in the third quarter of 2023</li>
<li>Adjusted EBITDA was $5.3 million, compared to $3.25 million in the same period last year.</li>
<li>Consolidated cash flow from operations was $4.3 million compared with $12.1 million in the corresponding quarter of 2023.</li>
</ul>
DeGiglio added that the company continued sales increases to its German, Australian and UK partners and that its Dutch business has "the potential to become a strong contributor of profitability and cash flow generation, driven by more favorable pricing and taxes in the Dutch market compared to Canada."
<h2 class="wp-block-heading">Price Action</h2>
Village Farms shares closed Wednesday's market session 11.02% lower at 80 cents per share.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/41793174/cannabis-stocks-collapse-after-trump-win-major-players-see-double-digit-declines-at-wednesdays-c">Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday&#8217;s Close</a></li>
</ul>
Photo: Courtesy of&nbsp;HTWE&nbsp;via Shutterstock&nbsp;

Cannabis

Earnings

News

Village Farms Quarterly Revenue Grows 20% YoY As The Cannabis Company Doubles International Sales

Legal

CPRI

Tapestry's CEO Said U.S. Judge's Decision To Block The Capri Deal Is Incorrect On Law, Facts; Confirmed They Have Appealed Decision, As Required By Merger Agreement -Conf Call

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Farcher.com%2F&amp;esheet=54148628&amp;newsitemid=20241107033638&amp;lan=en-US&amp;anchor=Archer+Aviation+Inc.&amp;index=1&amp;md5=7b557990d098d45c85a463f728f06dec">Archer Aviation Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) and Soracle Corporation (Soracle), a joint venture newly established by Japan Airlines and Sumitomo Corporation, signed agreements focused on bringing advanced air mobility (AAM) services to Japan.
&nbsp;
Soracle plans to launch its AAM operation in Japan using Archer's <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Farcher.com%2Faircraft&amp;esheet=54148628&amp;newsitemid=20241107033638&amp;lan=en-US&amp;anchor=Midnight&amp;index=2&amp;md5=8aa347ea8b40f05cbc6f494120a7c6ec">Midnight</a> aircraft, with the goal of offering electric air taxi flights in cities where existing ground transportation is constrained by traffic or geographic barriers.
To do so, Soracle has obtained the right to place aircraft orders of up to 100 Midnight aircraft, totaling approximately $500M, which would include pre-delivery payments based on certain milestones in advance of aircraft delivery.
Soracle will develop a variety of flight routes in attractive areas for residents as well as domestic and international visitors. Route locations could include places like Tokyo, Osaka, Nagoya, Hokkaido, Setouchi and Okinawa with the aim of establishing a transportation network that creates new value through mobility in the sky.
Archer and Soracle will work closely with the Japanese Civil Aviation Bureau (JCAB) to obtain the necessary permissions and certifications. Archer and JCAB have already begun discussions and Archer intends to work to certify our aircraft in Japan.
To memorialize this joint agreement, Soracle and Archer held a signing ceremony in Tokyo on September 26, 2024.

Global

ACHR

Archer Aviation And Soracle, A Joint Venture Newly Established By Japan Airlines And Sumitomo Corporation, Signed Agreements Focused On Bringing Advanced Air Mobility Services To Japan; Soracle Has Obtained The Right To Place Aircraft Orders Of Up To 100 Midnight Aircraft, Totaling ~$500M

Dividends

Regency Centers Increases Quarterly Dividend From $0.67 To $0.705 Per Share

WIIM

Ralph Lauren shares are trading higher after the company reported better-than-expected Q2 financial results.

During the quarter, the Company made a $17.5 million voluntary prepayment to its syndicate term loan facility. The Company ended the quarter with approximately $26.5 million remaining under the current share repurchasing program.

Buybacks

TGLS

Tecnoglass Expands Share Repurchase Program To $100M

CTVA

Corteva shares are trading lower after the company reported worse-than-expected Q3 financial results and issued FY24 sales guidance with its midpoint below estimates.

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and raises the price target from $64 to $69.

Price Target

Analyst Ratings

RYTM

HC Wainwright & Co. Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $69

PepGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEPG#NASDAQ">PEPG</a>) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.87) by 24.14 percent. This is a 32.65 percent increase over losses of $(0.98) per share from the same period last year.

Earnings Beats

PEPG

PepGen Q3 EPS $(0.66) Beats $(0.87) Estimate

Tecnoglass Board Approves 36% Increase In Quarterly Dividend From $0.11 To $0.15 Per Share

Biotech

Health Care

General

ENSC

Ensysce Biosciences Has Received Notice From The Nasdaq Stock Market That The Company May Continue Its Listing On The Nasdaq Capital Market Tier With An Extension To November 14

Global Indemnity Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBLI#NYSE">GBLI</a>) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of $0.57 by 66.67 percent. This is a 69.64 percent increase over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $111.761 million which missed the analyst consensus estimate of $123.000 million by 9.14 percent. This is a 11.34 percent decrease over sales of $126.061 million the same period last year.

Earnings Misses

GBLI

Global Indemnity Group Q3 2024 Adj. EPS $0.95 Beats $0.57 Estimate, Sales $111.761M Miss $123.000M Estimate

Nortech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSYS#NASDAQ">NSYS</a>) reported quarterly losses of $(0.27) per share. This is a 164.29 percent decrease over earnings of $0.42 per share from the same period last year. The company reported $31.41 million in sales this quarter. This is a 5.88 percent decrease over sales of $33.37 million the same period last year.

NSYS

Nortech Systems Q3 EPS $(0.27) Down From $0.42 YoY, Sales $31.41M Down From $33.37M YoY

MEDIROM Healthcare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) announced a business alliance with SBC Medical Group Holdings Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBC#NASDAQ">SBC</a>) a global owner, operator and provider of management services and products to cosmetic treatment centers.
Our two leading healthcare service providers have more than 4 million members across their loyalty programs at SBC's "Shonan Beauty Clinic" and MEDIROM's "Re.Ra.Ku wellness salon". In addition to bringing customers enhanced offerings and expertise, the alliance will seek to create compelling, integrated opportunities to harness the power of these loyal customers and reward them when they receive services at SBC Medical and MEDIROM.

MEDIROM Healthcare Technologies And SBC Medical Group Holdings Announce Business Alliance, Bringing Customers Enhanced Offerings And Expertise, The Alliance Will Seek To Create Compelling, Integrated Opportunities To Harness The Power Of These Loyal Customers And Reward Them When They Receive Services At SBC Medical And MEDIROM

LakeShore Biopharma Initiates Biologics License Application Of PIKA Rabies Vaccine To The Drug Regulatory Authority Of Pakistan

XELA

On November 6, 2024, The Nasdaq Stock Market Notified Exela Technologies That The Nasdaq Hearings Panel Has Determined To Delist The Company's Common Stock And That Trading Of The Company's Securities Will Be Suspended At The Open Of Trading On November 8-Filing

OTR Global downgrades Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) from Mixed to Negative.

Downgrades

PANW

OTR Global Downgrades Palo Alto Networks to Negative

Schwab Asset Management&#xAE;, the asset management arm of The Charles Schwab Corporation, today announced the launch of the Schwab Mortgage-Backed Securities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMBS#NYSE">SMBS</a>). The first day of trading is expected to be on or about November 19.
With an expense ratio of 0.03%, the Schwab Mortgage-Backed Securities ETF is priced in line with the lowest-priced peer ETFs based on the U.S. Mortgage Lipper category1. The ETF will provide simple access to investment-grade mortgage-backed securities issued and/or guaranteed by U.S. government agencies. It is designed to serve as part of a diversified portfolio.

ETFs

SCHW

SMBS

Schwab Asset Management To Launch The Schwab Mortgage-Backed Securities ETF "SMBS" On Or About November 19

STGW

Stagwell Reveals $125M Increase In Stock Repurchase Program

Needham analyst Joseph Stringer reiterates Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with a Hold.

Reiteration

GILD

Needham Reiterates Hold on Gilead Sciences

An announcement from Quantum-Si (QSI) is now available. Quantum-Si Incorporated has welcomed Charles "Chuck" Kummeth as the new Chairperson of the ...

Quantum-Si Appoints New Chairperson with Biomedical Expertise

Quantum-Si (QSI) has shared an announcement. Quantum-Si Incorporated has released an updated corporate presentation, offering an insight into its b...

Quantum-Si Shares Corporate Update with Investors

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
In most circumstances, you should avoid extremely speculative ideas, especially those billed as cheap <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>. It&rsquo;s difficult to find hard statistics regarding the odds of success in this arena, in large part because of the diversity of enterprises and industries involved. However, to put it colloquially, the odds aren&rsquo;t good at all.



We know this because if it the odds were favorable, everybody would bet on cheap penny stocks. But it&rsquo;s not that easy and most times, the underlying entities lose considerable value. Many simply go out of business.



Nevertheless, the sector will always attract new generations of speculators because of the promise of quick riches. Thanks to the typically small float along with rock-bottom pricing, one piece of good news could send shares flying. Sometimes, the target equities can pop for no reason whatsoever.



That&rsquo;s the allure but that&rsquo;s also the risk because let&rsquo;s face it &ndash; the opposite is true as well. If you can handle the heat, below are possibly cheap penny stocks to consider.



<h2>Red Cat (RCAT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/drone-war-300x169.png" alt="A drone being used by soldiers."><div>Source: Gorodenkoff / Shutterstock.com</div></div>I&rsquo;m starting this list of cheap penny stocks with Red Cat (NASDAQ:<a href="https://investorplace.com/stock-quotes/rcat-stock-quote/">RCAT</a>) primarily for its core drone business. <a href="https://finance.yahoo.com/quote/RCAT/profile/">Per its public profile</a>, Red Cat builds infrastructure to manage drone fleets. It also provides services for drones, which include empowering them to fly in confined industrial interior spaces. Most importantly for this discussion, the business carries significant military implications.



Fundamentally, the nature of warfare may be changing before our eyes. At first, Russia&rsquo;s invasion of Ukraine seemed like an easy affair for the belligerent nation: it&rsquo;s so much bigger than its neighbor. However, Ukrainian forces managed to better even the odds thanks to its use of drones as weapons. That caught the eye of the military industrial complex and could give RCAT stock a nice pop.



Interestingly, RCAT trades at 3.59X trailing-year sales. In the past year, this metric averaged about 5.3X. So, in that sense, it&rsquo;s undervalued. For fiscal 2024, experts see a mitigation of red ink to 35 cents per share. However, the big item is revenue, which could jump to $18.14 million. That&rsquo;s up 83% from last year, making RCAT one of the cheap penny stocks to consider.



<h2>Innoviz (INVZ)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/12/lidar-stocks-300x169.jpg" alt="LiDAR sensors show car sensing traffic around it. LAZR"><div>Source: Shutterstock</div></div>Based in Israel, Innoviz (NASDAQ:<a href="https://investorplace.com/stock-quotes/invz-stock-quote/">INVZ</a>) falls under the consumer cyclical sector, specifically the auto parts industry. <a href="https://finance.yahoo.com/quote/INVZ/profile/">Per its corporate profile</a>, Innoviz manufactures and sells automotive-grade lidar sensors and perception software. Ultimately, the company aims to enable safe autonomous driving at scale. Currently, the company offers InnoivzOne, which is a lidar sensor for auto manufacturers and robotaxi specialists.



To be fair, what makes INVZ stock rather risky is that we&rsquo;re still far off from the vision of fully autonomous vehicles. However, as we&rsquo;re seeing with artificial intelligence, innovation can move at breakneck speeds. During the trailing 12 months (TTM), the company incurred a net loss of nearly $119 million. However, revenue came out to $26.92 million and is growing at a blistering pace.



Even with the growth, shares trade at 5.46X trailing-year sales. In the past year, however, the metric averaged over 52X. Of course, that gives you an idea of how volatile INVZ stock has been in the market. Nevertheless, analysts project that sales will hit $32.45 million by year&rsquo;s end. If so, that would imply a 55.4% leap from last year&rsquo;s tally of $20.88 million.



If you like big wagers, INVZ could be one of the cheap penny stocks to consider.



<h2>Quantum-Si (QSI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/medical-bills-1600-300x169.png" alt="Doctor or physician calculating a patients medical bills at a desk. Medical bills, health costs, health expenses."><div>Source: THICHA SATAPITANON / Shutterstock</div></div>Headquartered in Branford, Connecticut, Quantum-Si (NASDAQ:<a href="https://investorplace.com/stock-quotes/qsi-stock-quote/">QSI</a>) falls under the broader healthcare sector, specifically medical devices. <a href="https://finance.yahoo.com/quote/QSI/profile/">According to its corporate profile</a>, Quantum-Si engages in the development of single-molecule detection platforms to enable next-generation protein sequencing (or NGPS). It offers instruments, software and reagent kits for the purposes of forwarding NGPS.



As you might imagine, the company isn&rsquo;t yet profitable. In the past four quarters, its average loss per share came out to 16.3 cents. That said, analysts anticipated that the red ink would amount to 19.3 cents. Technically speaking, then, QSI stock enjoys an &ldquo;earnings&rdquo; surprise of 15.4%.



In the TTM period, Quantum-Si incurred a net loss of $91.82 million or 65 cents per share. Revenue during the cycle hit $1.28 million. However, the growth trend is incredibly robust. For fiscal 2024, covering experts believe that sales could hit $4.02 million. If so, we&rsquo;re talking an expansion of 271.5%.



Not only that, in the following year, sales could soar to $12.4 million. That would be up another 208.5%. If you believe in these projections, QSI could be one of the cheap penny stocks to consider.



On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.



Read More: &#8239;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">Penny Stocks &mdash;&nbsp;How to Profit Without Getting Scammed</a>



On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/07/3-super-cheap-penny-stocks-for-the-ultimate-speculator/">3 Super-Cheap Penny Stocks for the Ultimate Speculator</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

3 Super-Cheap Penny Stocks for the Ultimate Speculator

Quantum-Si Q2 2024 Earnings Preview

Quantum-Si GAAP EPS of -$0.16 beats by $0.03, revenue of $622M beats by $621.32M

Quantum-Si incorporated (QSI) Q2 2024 Earnings Call Transcript

Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Quantum-Si (QSI – Research Report) and keeping the price target at $...

Buy Rating Affirmed for Quantum-Si on Strong Financials and Promising Product Pipeline

Quantum-Si (QSI) has shared an announcement. Quantum-Si Incorporated has updated its corporate presentation, now available for investors and the br...

Quantum-Si Shares Updated Corporate Presentation

Quantum-Si (QSI) has shared an announcement. Grace Johnston, Ph.D. has stepped down as Chief Commercial Officer of Quantum-Si Incorporated, with he...

Quantum-Si Announces Executive Leadership Transition

Warning: QSI is at high risk of performing badly

INVZ

QSIAW

RCAT

Press Releases

Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider

Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development

Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024

Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing

Comments

Quantum-Si

Notizie

Ultime notizie per Quantum-Si (NASDAQ:QSI) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO